Skip to main content

Advertisement

Log in

Bariatric Surgery to Prevent and Treat Diabetes

  • Obesity and Diet (G Rao, Section Editor)
  • Published:
Current Cardiovascular Risk Reports Aims and scope Submit manuscript

Abstract

The obesity epidemic has become a significant issue worldwide. Type 2 diabetes mellitus (T2DM) is related and its prevalence is also on the rise. Bariatric surgery as part of a comprehensive weight management strategy is highly efficacious in treating obese individuals and promoting weight loss. The resultant loss of excess body weight is frequently associated with improvement of comorbid factors such T2DM. This review focuses on both restrictive and malabsorptive bariatric surgical procedures and explores their roles in preventing and treating T2DM. Currently, the use of bariatric surgery as a prevention strategy for T2DM in obese individuals is understudied; however, there is early evidence to suggest a protective effect. In addition, this review summarizes emerging evidence linking bariatric surgery and improvement of T2DM in diabetic obese patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Reference

Recent publications of particular interest have been highlighted as: • Of importance

  1. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14(3):173–94.

    Article  PubMed  CAS  Google Scholar 

  2. DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. 2001;161(3):397–405.

    Article  Google Scholar 

  3. WHO. Diabetes: Fact Sheet. 2011;Fact Sheet n. 312.

  4. Public Health Agency of Canada. Report from the National Diabetes Surveillance System: Diabetes in Canada, 2009. 2009; Available at: http://www.phac-aspc.gc.ca/publicat/2009/ndssdic-snsddac-09/2-eng.php. Accessed May 8, 2011.

  5. Mokdad AH, Ford ES, Bowman BA, Nelson DE, Engelgau MM, Vinicor F, et al. Diabetes trends in the U.S.: 1990–1998. Diabetes Care. 2000;23(9):1278–83.

    Article  PubMed  CAS  Google Scholar 

  6. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282(16):1523–9.

    Article  PubMed  CAS  Google Scholar 

  7. • Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377(9765):557–67. This study describes the global trends of obesity.

    Article  PubMed  Google Scholar 

  8. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond). 2008;32(9):1431–7.

    Article  CAS  Google Scholar 

  9. WHO. Obesity and Overweight. 2011;Fact sheet 311.

  10. Tjepkema M. Adult obesity in Canada: measured height and weight. Nutrition: Findings from the Canadian Community Health Survey 2005(1).

  11. Statistics Canada. Canadian health measures survey: adult obesity prevalence in Canada and the United States. 2011; Available at: http://www.statcan.gc.ca/daily-quotidien/110302/dq110302c-eng.htm. Accessed May 10, 2011.

  12. Bonadonna RC, Groop L, Kraemer N, Ferrannini E, Del Prato S, DeFronzo RA. Obesity and insulin resistance in humans: a dose-response study. Metabolism. 1990;39(5):452–9.

    Article  PubMed  CAS  Google Scholar 

  13. Spiegelman D, Israel RG, Bouchard C, Willett WC. Absolute fat mass, percent body fat, and body-fat distribution: which is the real determinant of blood pressure and serum glucose? Am J Clin Nutr. 1992;55(6):1033–44.

    PubMed  CAS  Google Scholar 

  14. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab. 2001;280(5):E745–51.

    PubMed  CAS  Google Scholar 

  15. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.

    Article  PubMed  CAS  Google Scholar 

  16. Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess 2009 Sep;13(41):1-190, 215-357, iii-iv.

  17. Lau DC, Douketis JD, Morrison KM, Hramiak IM, Sharma AM, Ur E, et al. 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ. 2007;176(8):S1–S13.

    Article  PubMed  Google Scholar 

  18. O'Brien PE, Dixon JB, Laurie C, Skinner S, Proietto J, McNeil J, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med. 2006;144(9):625–33.

    PubMed  Google Scholar 

  19. Dixon JB, Strauss BJ, Laurie C, O'Brien PE. Changes in body composition with weight loss: obese subjects randomized to surgical and medical programs. Obesity (Silver Spring). 2007;15(5):1187–98.

    Article  Google Scholar 

  20. Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316–23.

    Article  PubMed  CAS  Google Scholar 

  21. Bessler M, Daud A, Kim T, DiGiorgi M. Prospective randomized trial of banded versus nonbanded gastric bypass for the super obese: early results. Surg Obes Relat Dis. 2007;3(4):480–4. discussion 484-5.

    Article  PubMed  Google Scholar 

  22. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.

    Article  PubMed  Google Scholar 

  23. Buddeberg-Fischer B, Klaghofer R, Krug L, Buddeberg C, Muller MK, Schoeb O, et al. Physical and psychosocial outcome in morbidly obese patients with and without bariatric surgery: a 4 1/2-year follow-up. Obes Surg. 2006;16(3):321–30.

    Article  PubMed  Google Scholar 

  24. Stoeckli R, Chanda R, Langer I, Keller U. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes Res. 2004;12(2):346–50.

    Article  PubMed  CAS  Google Scholar 

  25. • Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–256.e5. This meta-analysis highlights the improvement in T2DM following bariatric surgery.

    Article  PubMed  Google Scholar 

  26. Pontiroli AE, Laneri M, Veronelli A, Frige F, Micheletto G, Folli F, et al. Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parameters. Cardiovasc Diabetol. 2009;8:37.

    Article  PubMed  Google Scholar 

  27. • Rizzello M, Abbatini F, Casella G, Alessandri G, Fantini A, Leonetti F, et al. Early postoperative insulin-resistance changes after sleeve gastrectomy. Obes Surg. 2010;20(1):50–5. This study suggest that changes in insulin resistance may occur early in the postoperative period following sleeve gastrectomy.

    Article  PubMed  Google Scholar 

  28. Al Harakeh AB, Burkhamer KJ, Kallies KJ, Mathiason MA, Kothari SN. Natural history and metabolic consequences of morbid obesity for patients denied coverage for bariatric surgery. Surg Obes Relat Dis. 2010;6(6):591–6.

    Article  PubMed  Google Scholar 

  29. Gill RS, Birch DW, Shi X, Sharma AM, Karmali S. Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review. Surg Obes Relat Dis. 2010;6(6):707–13.

    Article  PubMed  Google Scholar 

  30. Lakdawala MA, Bhasker A, Mulchandani D, Goel S, Jain S. Comparison between the results of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass in the Indian population: a retrospective 1 year study. Obes Surg. 2010;6:707–13.

    Article  Google Scholar 

  31. Lirosi F. El Kallaawi M, Batterham RL, Adamo M. Do we need bypass surgery to cure diabetes? Prompt remission of diabetes after laparoscopic sleeve gastrectomy - a UK experience. Surg Obes Relat Dis. 2010;6:229–30.

    Article  Google Scholar 

  32. Shah S, Todkar J, Shah P. Effect of laparoscopic sleeve gastrectomy (LSG) on HbA1c levels in T2DM patients: results after one year. Obes Surg IFSO. 2009;Abstract P-071.

  33. Basso N, Leonetti F, Mariani PP, et al. Early hormonal changes after sleeve gastrectomy in diabetic obese patients. Obes Surg IFSO. 2009;Abstract P-064.

  34. Berry M, Villagran R, Lamoza P, et al. Laparoscopic sleeve gastrectomy (LSG) impact in diabetic (T2DM) obese patients. Obes Surg IFSO. 2009;Abstract P-084.

  35. Chowbey PK, Dhawan K, Khullar R, et al. Laparoscopic sleeve gastrectomy: an Indian experience - surgical technique and early results. Obes Surg Epub 2009.

  36. Jacobs M, Bisland W, Gomez E, et al. Laparoscopic sleeve gastrectomy: a retrospective review of 1- and 2-year results. Surg Endosc. 2010;24:781–5.

    Article  PubMed  Google Scholar 

  37. Cottam D, Qureshi FG, Mattar SG, et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc. 2006;20:859–63.

    Article  PubMed  CAS  Google Scholar 

  38. Vidal J, Ibarzabal A, Romero F, et al. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg. 2008;18:1077–82.

    Article  PubMed  CAS  Google Scholar 

  39. Moon Han S, Kim WW, Oh JH. Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients. Obes Surg. 2005;15:1469–75.

    Article  PubMed  Google Scholar 

  40. • Todkar JS, Shah SS, Shah PS, Gangwani J. Long-term effects of laparoscopic sleeve gastrectomy in morbidly obese subjects with type 2 diabetes mellitus. Surg Obes Relat Dis. 2010;6(2):142–5. This study describes the long-term weight loss and improvement in T2DM following sleeve gastrectomy.

    Article  PubMed  Google Scholar 

  41. Trostler N, Mann A, Zilberbush N, Avinoach E, Charuzi II. Weight Loss and Food Intake 18 Months following Vertical Banded Gastroplasty or Gastric Bypass for Severe Obesity. Obes Surg. 1995;5(1):39–51.

    Article  PubMed  Google Scholar 

  42. Halmi KA, Mason E, Falk JR, Stunkard A. Appetitive behavior after gastric bypass for obesity. Int J Obes. 1981;5(5):457–64.

    PubMed  CAS  Google Scholar 

  43. Pournaras DJ, Osborne A, Hawkins SC, Vincent RP, Mahon D, Ewings P, et al. Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg. 2010;252(6):966–71.

    Article  PubMed  Google Scholar 

  44. Cummings DE, Overduin J, Shannon MH, Foster-Schubert KE. 2004 ABS Consensus Conference. Hormonal mechanisms of weight loss and diabetes resolution after bariatric surgery Surg Obes Relat Dis. 2005;1(3):358–68.

    Google Scholar 

  45. Drucker DJ. Glucagon-like peptide-1 and the islet beta-cell: augmentation of cell proliferation and inhibition of apoptosis. Endocrinology. 2003;144(12):5145–8.

    Article  PubMed  CAS  Google Scholar 

  46. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238(4):467–84. discussion 84-5.

    PubMed  Google Scholar 

  47. Pories WJ. Diabetes: the evolution of a new paradigm. Ann Surg. 2004;239(1):12–3.

    Article  PubMed  Google Scholar 

  48. Cummings DE, Shannon MH. Roles for ghrelin in the regulation of appetite and body weight. Arch Surg. 2003;138(4):389–96.

    Article  PubMed  CAS  Google Scholar 

  49. Broglio F, Arvat E, Benso A, Gottero C, Muccioli G, Papotti M, et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab. 2001;86(10):5083–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

No conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richdeep S. Gill.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gill, R.S., Whitlock, K., Sandhu, R.K. et al. Bariatric Surgery to Prevent and Treat Diabetes. Curr Cardiovasc Risk Rep 6, 135–140 (2012). https://doi.org/10.1007/s12170-011-0218-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12170-011-0218-9

Keywords

Navigation